Mw Obesity-Drug Maker Metsera Posts Largest Gain As Ipos Defy Market Swoon

Investing.com -- Metsera, a clinical-stage biotechnology firm, debuted on the Nasdaq Global Select Market today. After initially offering its common stock to the public at $18.00 per share, the company's shares opened for trading at a higher price of $25.50.

The initial public offering (IPO) consisted of 15,277,778 shares of the company's common stock. The shares are now trading under the ticker symbol "MTSR" on the Nasdaq Global Select Market.

Several prominent financial firms, including BofA Securities, Goldman Sachs & Co (NYSE:GS). LLC, Evercore ISI, Guggenheim Securities, and Cantor, are acting as joint bookrunners for the offering.

In addition to the initial offering, Metsera has also provided the underwriters with a 30-day option. This option allows them to purchase up to an additional 2,291,666 shares of the company's common stock. However, these additional shares would be available at the initial public offering price minus any underwriting discounts and commissions.

Metsera is not just any biotech firm. It's a clinical-stage company that is working on next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides. The company's primary focus is on treating obesity, overweight, and related health conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Infinity Natural Resources, an independent energy company, has launched its initial public offering (IPO) today. The company priced 13,250,000 shares of its Class A common stock at $20.00 each. Trading commenced on the New York Stock Exchange (NYSE) under the ticker symbol "INR", opening at $22.16 per share.

The IPO is managed by a host of financial institutions. Citigroup (NYSE:C), Raymond (NSE:RYMD) James, and RBC Capital Markets are acting as joint book-running managers. Other joint book-running managers include BofA Securities, Capital One (NYSE:COF) Securities, and Truist Securities. KeyBanc Capital Markets and Stephens Inc. are serving as senior co-managers. Additionally, Comerica (NYSE:CMA) Securities, Fifth Third Securities, First Citizens Capital Securities, and BTIG are acting as co-managers. BOK Financial Securities, Inc. and Zions Capital Markets have been designated as junior co-managers.

The company has also provided the underwriters with an option to buy up to an extra 1,987,500 shares of common stock. This option is at the initial public offering price, but it is less the underwriting discounts and commissions.

Infinity Natural Resources is a growth-oriented company that generates free cash flow. It is focused on acquiring, developing, and producing hydrocarbons in the Appalachian Basin. The company's operations are concentrated on the volatile oil window of the Utica Shale in eastern Ohio. It also has stacked dry gas assets in both the Marcellus and Utica Shales in southwestern Pennsylvania.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.